Lista de obras - Guglielmo Nasti - Dominio Público Uruguay

A liver angioma colonized by colon cancer cells in a patient with two primitive localizations by colon adenocarcinoma: biologic, diagnostic and therapeutic implications

artículo científico publicado en 2005

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

artículo científico publicado en 2015

AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive

artículo científico publicado en 2003

Access to Antiretroviral Treatment, Incidence of Sustained Therapy Interruptions, and Risk of Clinical Events According to Sex

artículo científico publicado en 2003

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment

artículo científico publicado en 2017

Best Sequence Therapy in RAS Wild-Type Metastatic Colorectal Cancer: Waiting for Randomized Crossover Clinical Trials

artículo científico publicado en 2016

Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer.

artículo científico publicado en 2008

CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients

artículo científico publicado en 2016

Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study

artículo científico publicado en 2009

Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection

artículo científico publicado en 1999

Concomitant occurrence of facial cutaneous and parotid gland metastases from rectal cancer after preoperative chemoradiotherapy

artículo científico publicado en 2007

Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests

artículo científico publicado en 2013

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

artículo científico publicado en 2016

Diabetes mellitus following intravenous pentamidine administration in a patient with HIV infection

scientific article published on 01 March 1995

Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis

artículo científico publicado en 2001

Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging

artículo científico publicado en 2015

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

artículo científico publicado en 2013

Erratum to: Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction

scholarly article published in Investigational New Drugs

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.

artículo científico publicado en 2011

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

artículo científico publicado en 2012

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.

artículo científico publicado en 2018

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice ⬇️

artículo científico publicado en 2019

Gastric cancer. Treatment of advanced disease and new drugs.

artículo científico publicado en 2005

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?

artículo científico publicado en 2013

Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.

artículo científico publicado en 2005

Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma

article

Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma

scientific article published on 01 September 1998

Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.

artículo científico publicado en 2016

Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2

artículo científico publicado en 1999

Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.

artículo científico publicado en 2003

Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.

artículo científico publicado en 2003

Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.

artículo científico publicado en 2003

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

artículo científico publicado en 2018

Malignant tumors and AIDS ⬇️

artículo científico publicado el 1 de enero de 1997

Metastatic colorectal cancer: role of target therapies and future perspectives

artículo científico publicado en 2017

Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.

artículo científico publicado en 2017

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.

artículo científico publicado en 2013

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

artículo científico publicado en 2006

Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients.

artículo científico publicado en 2013

Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)

artículo científico publicado en 2011

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).

artículo científico publicado en 2015

Phase II studies of anticancer chemotherapy: indirect evidence of poor quality

artículo científico publicado en 2006

Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials.

artículo científico publicado en 2010

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition

artículo científico publicado en 2012

Prognostic and predictive response factors in colorectal cancer patients: between hope and reality

artículo científico publicado en 2014

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

artículo científico publicado en 2016

Quantification of Hepatitis C Virus (HCV) in Liver Specimens and Sera from Patients with Human Immunodeficiency Virus Coinfection by Using the Versant HCV RNA 3.0 (Branched DNA-Based) DNA Assay

artículo científico publicado en 2003

Serum and tissue markers in colorectal cancer: State of art.

artículo científico publicado en 2017

Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction.

artículo científico publicado en 2009

Small tumor of the medial breast presenting with a contralateral lymph node involvement detected on positron emission tomography scan.

artículo científico publicado en 2007

Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients

article

The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.

artículo científico publicado en 2015

Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.

artículo científico publicado en 2008

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

artículo científico publicado en 2016

[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab].

artículo científico publicado en 2015

Lista de obras de Guglielmo Nasti

A liver angioma colonized by colon cancer cells in a patient with two primitive localizations by colon adenocarcinoma: biologic, diagnostic and therapeutic implications

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive

Access to Antiretroviral Treatment, Incidence of Sustained Therapy Interruptions, and Risk of Clinical Events According to Sex

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment

Best Sequence Therapy in RAS Wild-Type Metastatic Colorectal Cancer: Waiting for Randomized Crossover Clinical Trials

Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer.

CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients

Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study

Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection

Concomitant occurrence of facial cutaneous and parotid gland metastases from rectal cancer after preoperative chemoradiotherapy

Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

Diabetes mellitus following intravenous pentamidine administration in a patient with HIV infection

Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis

Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Erratum to: Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice ⬇️

Gastric cancer. Treatment of advanced disease and new drugs.

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?

Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.

Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma

Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma

Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.

Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2

Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.

Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.

Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

Malignant tumors and AIDS ⬇️

Metastatic colorectal cancer: role of target therapies and future perspectives

Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients.

Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).

Phase II studies of anticancer chemotherapy: indirect evidence of poor quality

Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials.

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition

Prognostic and predictive response factors in colorectal cancer patients: between hope and reality

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

Quantification of Hepatitis C Virus (HCV) in Liver Specimens and Sera from Patients with Human Immunodeficiency Virus Coinfection by Using the Versant HCV RNA 3.0 (Branched DNA-Based) DNA Assay

Serum and tissue markers in colorectal cancer: State of art.

Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction.

Small tumor of the medial breast presenting with a contralateral lymph node involvement detected on positron emission tomography scan.

Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients

The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.

Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab].